Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood-Reference-Cited by-同舟云学术

Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood

Published:2022 Issue:1 Volume:69 Page:45-54
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Nishikawa Tetsuo¹,Satoh Fumitoshi²,Takashi Yuichi³,Yanase Toshihiko⁴,Itoh Hiroshi⁵,Kurihara Isao⁵,Shibata Hirotaka⁶,Oki Yutaka⁷,Naruse Mitsuhide⁸,Sasamoto Hidehiko⁹,Kuwa Katsuhiko¹⁰

Affiliation:

1. Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan

2. Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Division of Nehrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan

3. Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, Fukuoka, Japan

4. Muta Hospital, Fukuoka, Japan

5. Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan

6. Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Japan

7. Department of Metabolism and Endocrinology, Hamamatsu-Kita Hospital, Hamamatsu, Japan

8. Department of Endocrinology, Metabolism and Hypertension, National Hospital, Organization Kyoto Medical Center, Kyoto, Japan

9. Aska Pharma Medical Co. Ltd., Fujisawa, Japan

10. Japan Reference Measurement Institute, Tsukuba, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/69/1/69_EJ21-0278/_pdf

Reference14 articles.

1. 1 Review Committee on Standardization of Blood Aldosterone Measurements. Endocrine Society of Japan: Operational Guidelines for Standardization of Aldosterone Measurement in Daily Clinical Practice—Response to The Suspension of Supply of SPAC-S(RIA) Kit. (1st) April 2018, (2nd) February 2020 (In Japanese). http://www.j-endo.jp/modules/news/index.php?content_id=55 accessed on Feb.18, 2020.

2. 2 National Institute of Advanced Industrial Science and technology (AIST), National Metrology Institute of Japan Reference Material Certificate: NMIJ CRM 6402: Aldosterone in Human Serum. http://unit.aist.go.jp/qualmanmet/refmate/crm/cert/6402b_J.pdf accessed on April 1, 2020.

3. 3 Review Committee on Standardization of Blood Aldosterone Measurements: Standardization review committee for blood aldosterone measurement. Study report on standardization of aldosterone measurement in blood, February 29, 2016 (In Japanese).

4. 4 Nishikawa T, Omura M, Kawaguchi M, Takatsu A, Satoh F, et al. (2016) Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood. Endocr J 63: 1065–1080.

5. 5 Fries CM, Bae YJ, Rayes N, Sander B, Isermann B, et al. (2020) Prospective evaluation of aldosterone LC-MS/MS-specific cutoffs for the saline infusion test. Eur J Endocrinol 183: 191–201.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Where and how are we going? Simplifying the definitive diagnosis of primary aldosteronism;Hypertension Research;2024-04-08

2. Screening Cutoff Values for the Detection of Aldosterone-Producing Adenoma by LC-MS/MS and a Novel Noncompetitive CLEIA;Journal of the Endocrine Society;2024-04-06

3. Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study;Hypertension Research;2024-03-08

4. Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism;Endocrine Journal;2024

5. Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) <i>via</i> retrospective analyses in Okinawa, Japan;Endocrine Journal;2024